Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris M Parry

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Blood|January 9, 2007
Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalizationJulie Catusse, Chris M Parry, David R Dewin, et al.
The Journal of Infection|May 24, 2005
Breast abscess caused by Propionibacterium avidum following breast reduction surgery: case report and review of the literatureStavroula Panagea, John E Corkill, Martin J Hershman, et al.
The Journal of General Virology|November 1, 2013
Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1Katherine A Sutherland, Jean L Mbisa, Patricia A Cane, et al.
AIDS (London, England)|June 25, 2014
The arrival of untreatable multidrug-resistant HIV-1 in sub-Saharan AfricaBrian Magambo, Jamirah Nazziwa, Nicholas Bbosa, et al.
Plos Pathogens|October 12, 2012
Host-pathogen interaction in invasive SalmonellosisHanna K de Jong, Chris M Parry, Tom van der Poll, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacityChris M Parry, Madhavi Kolli, Richard E Myers, et al.
AIDS (London, England)|July 3, 2010
Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assaysRavindra K Gupta, Arinder Kohli, Adele L McCormick, et al.
Journal of Virology|July 10, 2009
Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1Chris M Parry, Arinder Kohli, Christine J Boinett, et al.
Retrovirology|July 4, 2014
Human immunodeficiency virus Tat associates with a specific set of cellular RNAsRussell D Bouwman, Anne Palser, Chris M Parry, et al.
AIDS Research and Human Retroviruses|May 24, 2012
Low drug resistance levels among drug-naive individuals with recent HIV type 1 infection in a rural clinical cohort in southwestern UgandaDeogratius Ssemwanga, Anne Kapaata, Frederick Lyagoba, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Blood|January 9, 2007
Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalizationJulie Catusse, Chris M Parry, David R Dewin, et al.
The Journal of Infection|May 24, 2005
Breast abscess caused by Propionibacterium avidum following breast reduction surgery: case report and review of the literatureStavroula Panagea, John E Corkill, Martin J Hershman, et al.
The Journal of General Virology|November 1, 2013
Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1Katherine A Sutherland, Jean L Mbisa, Patricia A Cane, et al.
AIDS (London, England)|June 25, 2014
The arrival of untreatable multidrug-resistant HIV-1 in sub-Saharan AfricaBrian Magambo, Jamirah Nazziwa, Nicholas Bbosa, et al.
Plos Pathogens|October 12, 2012
Host-pathogen interaction in invasive SalmonellosisHanna K de Jong, Chris M Parry, Tom van der Poll, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacityChris M Parry, Madhavi Kolli, Richard E Myers, et al.
AIDS (London, England)|July 3, 2010
Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assaysRavindra K Gupta, Arinder Kohli, Adele L McCormick, et al.
Journal of Virology|July 10, 2009
Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1Chris M Parry, Arinder Kohli, Christine J Boinett, et al.
Retrovirology|July 4, 2014
Human immunodeficiency virus Tat associates with a specific set of cellular RNAsRussell D Bouwman, Anne Palser, Chris M Parry, et al.
AIDS Research and Human Retroviruses|May 24, 2012
Low drug resistance levels among drug-naive individuals with recent HIV type 1 infection in a rural clinical cohort in southwestern UgandaDeogratius Ssemwanga, Anne Kapaata, Frederick Lyagoba, et al.
Pageof 4